Oseltamivir 15 mg/mL oral solution
Ingredients
| Ingredient | Role | For 100 mL |
|---|---|---|
| Oseltamivir (as phosphate) | active | 1.5 g |
| Sodium benzoate | preservative | See the study |
| Purified water | vehicle | q.s. to 100 mL |
- Strength
- 15 mg/mL
- Starting material
- Oseltamivir phosphate bulk powder (API)
- Container
- Type II amber glass bottles (125 mL), filled to allow for expansion on freezing
- Stored frozen up to 75 days, then refrigerated up to 10 days after thawing.
Amounts are ClinDose's arithmetic from the study's concentration; follow the study for the method.
Storage and beyond-use date
| Storage | BUD | Basis |
|---|---|---|
| Refrigerated | 10 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
| Frozen | 75 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.
Ingredient checks
No FDA compounding list or NIOSH flags for the active ingredient.
Source
Ramirez JCR, Sáez AG, Madrid MEM, Viney AC, Herreros JMA, Rojo PA. Stability Study of a Frozen Oseltamivir 15 mg/mL Oral Solution in Amber Glass Bottles. Pharmaceutics. 2026;18(9):1130. PMID 42797305. PMC13610113. License: CC BY (checked 2026-11-06). Read the article · DOI
For licensed clinicians. Use with clinical judgment.